| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Cdc42 effector protein 1;Binder of Rho GTPases 5;Serum protein MSE55;CDC42EP1;BORG5, CEP1, MSE55; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | A synthesized peptide derived from human RNF14 |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-RNF14 Rabbit Monoclonal Antibody catalog # M08956-1. Tested in WB application. This antibody reacts with Human, Mouse, Rat.
Protein: T-cell surface glycoprotein CD3 zeta chain | Gene: Cdc42 effector protein 1 | Target: RNF14 | Function: Probably involved in the organization of the actin cytoskeleton. Induced membrane extensions in fibroblasts. . | Research areas: Actin Assembly,Actin, etc.,Cytoskeleton,Cytoskeleton/ECM,Microfilaments,Signal Transduction
Host: Rabbit | Clonality/Clone: Monoclonal / Clone: 29R10 | Isotype: IgG | Reactivity: Human,Mouse,Rat | Immunogen: A synthesized peptide derived from human RNF14 | Concentration: 0.5mg/ml | Purification: Affinity-chromatography
Applications: WB
Observed MW: 54 kDa | Calculated MW: 40295 MW
Cellular localization: Endomembrane system ; Peripheral membrane protein . Cytoplasm, cytoskeleton .
Tissue details: Endothelial and bone marrow stromal cells.
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
